A new strategy for achieving appropriate antibiotic drug use, the mutant prevention concentration (MPC), was outlined by Joseph
M. Blondeau, MSc, PhD, RSM (CCM), SM (AAM), SM (ASCP), FCCP, in his presentation "Antibiotics and antimicrobial resistance."1
(GETTY IMAGES/SCIENCE PHOTO LIBRARY)
WHAT IS MPC?
MPC is a novel measurement meant to determine the drug concentration that blocks 100% of the growth of mutant bacterial cells
in high-density populations. This measurement allows assessment of the "likelihood for antimicrobial agents to select for
antimicrobial resistance at clinically relevant drug concentrations," said Dr. Blondeau. Clinically relevant drug concentrations
are the serum concentrations we are trying to achieve to eliminate the infection. A drug with a high MPC is likely to cause
Mutations confer resistance, and these mutations may not be detected at the bacterial concentrations typically used for culture
and sensitivity testing. According to Dr. Blondeau, these mutations occur at much higher bacterial concentrations, which are
more representative of the true bacterial burden. If MPC data are used for dosing, rather than the minimum inhibitory concentration
(MIC) data currently used, there may be a better chance of eradicating disease and less risk of inducing resistance.
Thus, the data we currently use for antibiotic selection are not as effective as decreasing the risk of inducing resistance.
MPC data may ultimately replace MIC data and allow for more effective antibiotic therapy.
Dr. Blondeau also noted some things practitioners can do to help stem the rise in antimicrobial resistance:
- Use alcohol-based rubs before and after all patient examinations.
- Establish more rigorous contact precautions between patients.
- Increase in-clinic educational efforts about proper infection control measures and antibiotic use.
1. Blondeau JM. Antibiotics and antimicrobial resistance. Presented at the Annual Meeting of the American College of Veterinary
Internal Medicine; June 2012.
This "Lecture Link" summary from the 2012 American College of Veterinary Internal Medicine Forum was contributed by Jennifer
L. Garcia, DVM, DACVIM, a veterinary internal medicine specialist at Sugarland Veterinary Specialists in Houston, Texas.
Dr. Jennifer L. Garcia